On August 17, Astera Labs, Inc. rose 8.67% in regular trading, trading at $344.695/share, with turnover of $194 million. The rally was driven by Northland Securities upgrading the stock to Outperform from Market Perform with a $350 price target, adding to a wave of bullish analyst sentiment.

The upgrade follows a series of positive catalysts. Astera Labs reported Q2 adjusted EPS of $0.80, beating the $0.69 estimate, with revenue of $392.4 million surpassing the $360.7 million consensus. More notably, Q3 revenue guidance of $540-560 million far exceeded the prior $417 million market expectation. RBC Capital previously raised its target to $500, and Morgan Stanley lifted its target to $335, maintaining an Overweight rating. The consensus mean target now stands at $416.78.

The broader semiconductor sector also provided tailwinds, with Micron Technology up 3.53%, SK hynix up 3.59%, and NVIDIA up 0.37%, reinforcing the recovery momentum across AI infrastructure plays.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)